Protagenic Therapeutics, Inc.\new Quarterly Operating Income (Loss) in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Protagenic Therapeutics, Inc.\new quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q3 2024.
  • Protagenic Therapeutics, Inc.\new Operating Income (Loss) for the quarter ending September 30, 2024 was -$652K, a 54.5% increase year-over-year.
  • Protagenic Therapeutics, Inc.\new Operating Income (Loss) for the twelve months ending September 30, 2024 was -$5.27M, a 32.7% decline year-over-year.
  • Protagenic Therapeutics, Inc.\new annual Operating Income (Loss) for 2023 was -$4.53M, a 27.2% decline from 2022.
  • Protagenic Therapeutics, Inc.\new annual Operating Income (Loss) for 2022 was -$3.56M, a 14.1% increase from 2021.
  • Protagenic Therapeutics, Inc.\new annual Operating Income (Loss) for 2021 was -$4.14M, a 62.3% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$5.27M -$652K +$780K +54.5% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 -$6.05M -$1.67M -$524K -45.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 -$5.53M -$1.74M -$999K -135% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$4.53M -$1.21M -$556K -84.9% Oct 1, 2023 Dec 31, 2023 10-K/A 2024-05-14
Q3 2023 -$3.97M -$1.43M -$508K -54.9% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 -$3.46M -$1.14M -$507K -79.6% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 -$2.96M -$739K +$602K +44.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$3.56M -$656K +$205K +23.9% Oct 1, 2022 Dec 31, 2022 10-K/A 2024-05-14
Q3 2022 -$3.76M -$924K -$160K -20.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$3.6M -$637K +$672K +51.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$4.28M -$1.34M -$135K -11.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$4.14M -$861K -$411K -91.4% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$3.73M -$764K +$328K +30% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$4.06M -$1.31M -$820K -168% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$3.24M -$1.21M -$685K -132% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q4 2020 -$2.55M -$450K +$287K +39% Oct 1, 2020 Dec 31, 2020 10-K 2022-04-07
Q3 2020 -$2.84M -$1.09M -$902K -476% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$1.94M -$489K +$16.3K +3.23% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 -$1.95M -$521K +$133K +20.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 -$2.09M -$737K -$213K -40.6% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-25
Q3 2019 -$1.87M -$190K +$308K +61.9% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 -$2.18M -$505K +$180K +26.3% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 -$2.36M -$654K -$47.3K -7.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-06-18
Q4 2018 -$2.31M -$524K +$185K +26% Oct 1, 2018 Dec 31, 2018 10-K 2020-04-29
Q3 2018 -$2.5M -$498K +$29K +5.5% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 -$2.53M -$685K -$214K -45.3% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 -$2.31M -$607K +$51.2K +7.79% Jan 1, 2018 Mar 31, 2018 10-Q/A 2019-05-16
Q4 2017 -$2.37M -$709K -$153K -27.4% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-29
Q3 2017 -$2.21M -$527K -$72.2K -15.9% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 -$2.14M -$472K +$25.1K +5.05% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 -$2.17M -$658K +$67.8K +9.35% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 -$2.23M -$556K -$405K -268% Oct 1, 2016 Dec 31, 2016 10-K 2018-04-02
Q3 2016 -$1.83M -$455K -$94K -26% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-13
Q2 2016 -$1.73M -$497K -$396K -392% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-08
Q1 2016 -$1.34M -$726K -$676K -1354% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 -$663K -$151K -$14K -10.2% Oct 1, 2015 Dec 31, 2015 10-Q 2016-03-11
Q3 2015 -$649K -$361K -$243K -206% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-17
Q2 2015 -$406K -$101K Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-15
Q1 2015 -$49.9K +$348K +87.5% Jan 1, 2015 Mar 31, 2015 10-Q 2016-07-25
Q4 2014 -$137K +$105K +43.4% Oct 1, 2014 Dec 31, 2014 10-Q 2016-03-11
Q3 2014 -$118K +$88K +42.7% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-13
Q1 2014 -$398K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q4 2013 -$242K Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-06
Q3 2013 -$206K Jul 12, 2013 Sep 30, 2013 10-Q 2014-11-13
Q3 2011 -$5.02M -$1.35M -36.8% Jul 1, 2011 Sep 30, 2011 10-Q 2011-11-14
Q2 2011 -$5.02M -$535K -11.9% Apr 1, 2011 Jun 30, 2011 10-Q/A 2011-09-07
Q3 2010 -$3.67M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
Q2 2010 -$4.49M Apr 1, 2010 Jun 30, 2010 10-Q/A 2011-09-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.